Antihistamines effective in alopecia areata study
September 29th 2020A recent study published in the Journal of the American Academy of Dermatology found positive results when using antihistamines, along with topical corticosteroids and superficial cryotherapy, as a combination treatment for alopecia areata.
Weekly Roundup: September 21-25
September 25th 2020ICYMI, some of the content featured this week includes articles about how to choose a telemedicine vendor, the launch of an international COVID-19 dermatology registry, a study evaluating dupilumab’s durability versus cyclosporine in patients with atopic dermatitis, plus more.
AAD, NPF guidelines urge liver disease monitoring in psoriasis patients
September 25th 2020The latest guidelines for psoriasis from the American Academy of Dermatology and the National Psoriasis Foundation recommend physicians monitor their patients for liver disease when prescribed medication for psoriasis, such as methotrexate.
Cross-specialty collaboration key to tracking COVID-19 skin symptoms
September 24th 2020Esther Freeman, M.D., details the team effort made by the American Academy of Dermatology’s (AAD) COVID-19 Task Force to launch an international registry documenting skin manifestations in patients diagnosed with or suspected of COVID-19 infection.
How to choose a telemedicine vendor
September 22nd 2020With the increase in telemedicine use, physicians can (virtually) meet their patients’ needs now more than ever. However, with this swift increase in telehealth usage, how can physicians choose the best telemedicine vendor for their practice with so many options available?
FDA, EMA accepts marketing applications for bimekizumab in psoriasis
September 22nd 2020UCB announces the U.S. Food and Drug Administration and the European Medicines Agency have accepted the Biologics License Application and Marketing Authorization Application for bimekizumab for the treatment of moderate-to-severe plaque psoriasis in adults.
Weekly Roundup: September 14-18
September 18th 2020ICYMI, some of the content featured this week includes articles about a new diversity and equity initiative from Skinbetter Science and Allergan Aesthetics, patient sunscreen savviness, skin of color patients lacking in phase 3 psoriasis trials, plus more.
The Cutaneous Connection: Episode 7- Tips and Tricks for Treating Young Skin of Color Patients
September 17th 2020In this episode, Candrice Heath, M.D., sits down to discuss her recent presentation at the 2020 Skin of Color Update about clinical pearls for kids, tweens and teens with skin of color. Dr. Heath also explains the most common skin conditions for this patient group, treatment challenges, and much more.
FDA accepts NDA filing for topical papulopustular rosacea treatment
September 14th 2020The U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) filing for Sol-Gel’s Epsolay, a 5% microencapsulated benzoyl peroxide cream for the treatment of inflammatory lesions of rosacea or papulopustular rosacea.